Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

OHSU researchers produce first animal model for stress-induced movement disorder

02.04.2003


Research helps physicians understand rare form of ataxia that causes patients to appear ’drunk’ at times


Scientists at Oregon Health & Science University are the first to produce an animal model for episodic ataxia. The condition causes patients to suffer bouts of extreme clumsiness where they have balance, speech and motor difficulties. The research helps scientists better understand this rare and intriguing disorder. It may also help provide valuable information for improved, targeted drugs for treatment. The research is printed in the April edition of the journal Nature Neuroscience. It was conducted in conjunction with researchers at the Portland Veterans Affairs Medical Center.

"By developing a mouse model for episodic ataxia, we now have a valuable tool to better understand and treat the disease," said James Maylie, Ph.D., a professor of obstetrics and gynecology in the OHSU School of Medicine. "We have already used this animal model to observe and learn more about cellular mechanisms behind the disease. These disease-linked cells are located in the cerebellum, a portion of the brain involved in motor coordination."

The research also helps explain how a medication commonly used to treat patients works. "Acetazolamide is often given to patients with episodic ataxia," Maylie said. "Using these mice models, we were able to establish how acetazolamide acts at a cellular level to combat the disorder, something that was previously unknown."



Approximately 150,000 Americans are affected by the various forms of ataxia. The disorder is characterized by poor motor coordination. Specifically, it can cause hand coordination problems, poor balance and slurred speech. People with ataxia are often accused of acting drunk. In most ataxia disorders, the coordination problems are present all the time. In episodic ataxia, the coordination problems come on suddenly, often in stressful situations, and last for minutes or hours.

"Episodic ataxia is one form of the condition involving intermittent spells where sufferers simply can’t control their limbs," said John Nutt, M.D., director of the Parkinson Center of Oregon, which also treats patients with ataxia. "These attacks can last anywhere from a couple of minutes to three or four hours, and they are often triggered by stress, exercise or vigorous activity. In between episodes, patients are completely normal. Episodic ataxia is frequently caused by genetic mutations, but in some cases, multiple sclerosis can be the cause."

Years ago Nutt and his colleagues helped define clinical features of what they thought were three different types of inherited episodic ataxia while working with families seen in the OHSU neurogenetics clinic. In 1994 OHSU researchers Michael Litt, Ph.D., professor of molecular and medical genetics in the OHSU School of Medicine, and research associate David Browne, Ph.D., determined that the disease was caused in some families by a mutation in a gene that controls the flow of potassium in and out of nerve cells. This was the first human disease linked to the malfunction of a potassium gene. Testing all the families with this disorder in the neurogenetics clinic proved that two genes, and not three genes as the clinicians had thought, were responsible for the episodic ataxias. Subsequently other investigators found that a second variant of episodic ataxia was caused by a mutation in a gene that controlled the flow of calcium through the cell membrane.


This research was funded by the National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, and the National Ataxia Foundation.

Jim Newman | EurekAlert!
Further information:
http://www.ohsu.edu/

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>